Autophagy and liver cancer

키워드

참고문헌 (134)

1. Klionsky DJ, "Autophagy as a regulated pathway of cellular degradation", Science, 290, pp.1717~1721 (2000)
2. Parzych KR, "An overview of autophagy : morphology, mechanism, and regulation", Antioxid Redox Signal, 20, pp.460~473 (2014)
3. Mizushima N, "Autophagy fights disease through cellular self-digestion", Nature, 451, pp.1069~1075 (2008)
4. White E, "The role for autophagy in cancer", J Clin Invest, 125, pp.42~46 (2015)
5. Yang JD, "Hepatocellular carcinoma : a global view", Nat Rev Gastroenterol Hepatol, 7, pp.448~458 (2010)
6. Bray F, "Global cancer statistics 2018 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries", CA Cancer J Clin, 68, pp.394~424 (2018)
7. Xu J, "Trends in liver cancer mortality among adults aged 25 and over in the United States, 2000-2016", NCHS Data Brief, (314), pp.1~8 (2018)
8. Farazi PA, "Hepatocellular carcinoma pathogenesis : from genes to environment", Nat Rev Cancer, 6, pp.674~687 (2006)
9. Chao X, "Role and mechanisms of autophagy in alcoholinduced liver injury", Adv Pharmacol, 85, pp.109~131 (2019)
10. Ma X, "Role and mechanisms of mitophagy in liver diseases", Cells, 9, pp.837~ (2020)
11. Yang L, "Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance", Cell Metab, 11, pp.467~478 (2010)
12. Sir D, "Autophagy by hepatitis B virus and for hepatitis B virus", Autophagy, 6, pp.548~549 (2010)
13. Sir D, "Induction of incomplete autophagic response by hepatitis C virus via the unfolded protein response", Hepatology, 48, pp.1054~1061 (2008)
14. Chao X, "Impaired TFEB-mediated lysosome biogenesis and autophagy promote chronic ethanol-induced liver injury and steatosis in mice", Gastroenterology, 155, pp.865~879.e12 (2018)
15. Liang XH, "Induction of autophagy and inhibition of tumorigenesis by beclin 1", Nature, 402, pp.672~676 (1999)
16. Qu X, "Promotion of tumorigenesis by heterozygous disruption of the beclin 1autophagy gene", J Clin Invest, 112, pp.1809~1820 (2003)
17. Yue Z, "Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor", Proc Natl Acad Sci U S A, 100, pp.15077~15082 (2003)
18. Qiu DM, "The expression of beclin-1, an autophagic gene, in hepatocellular carcinoma associated with clinical pathological and prognostic significance", BMC Cancer, 14, pp.327~ (2014)
19. Kuma A, "The role of autophagy during the early neonatal starvation period", Nature, 432, pp.1032~1036 (2004)
20. Komatsu M, "Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice", J Cell Biol, 169, pp.425~434 (2005)
21. Takamura A, "Autophagy-deficient mice develop multiple liver tumors", Genes Dev, 25, pp.795~800 (2011)
22. Inami Y, "Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells", J Cell Biol, 193, pp.275~284 (2011)
23. Ni HM, "Nrf2 promotes the development of fibrosis and tumorigenesis in mice with defective hepatic autophagy", J Hepatol, 61, pp.617~625 (2014)
24. Ding WX, "Oncogenic transformation confers a selective susceptibility to the combined suppression of the proteasome and autophagy", Mol Cancer Ther, 8, pp.2036~2045 (2009)
25. Ding WX, "Sorting, recognition and activation of the misfolded protein degradation pathways through macroautophagy and the proteasome", Autophagy, 4, pp.141~150 (2008)
26. Chen N, "Autophagy and tumorigenesis", FEBS Lett, 584, pp.1427~1435 (2010)
27. Mathew R, "Autophagy suppresses tumorigenesis through elimination of p62", Cell, 137, pp.1062~1075 (2009)
28. Vessoni AT, "Autophagy and genomic integrity", Cell Death Differ, 20, pp.1444~1454 (2013)
29. Tian Y, "Autophagy inhibits oxidative stress and tumor suppressors to exert its dual effect on hepatocarcinogenesis", Cell Death Differ, 22, pp.1025~1034 (2015)
30. Ni HM, "Liver-specific loss of Atg5 causes persistent activation of Nrf2and protects against acetaminophen-induced liver injury", Toxicol Sci, 127, pp.438~450 (2012)
31. Yang H, "Sequestosome 1", p62 protein is associated with autophagic removal of excess hepatic endoplasmic reticulum in mice, 2016, pp.291, 18663~18674
32. Ni HM, "Dual roles of mammalian target of rapamycin in regulating liver injury and tumorigenesis in autophagy-defective mouse liver", Hepatology, 70, pp.2142~2155 (2019)
33. Khambu B, "HMGB1promotes ductular reaction and tumorigenesis in autophagydeficient livers", J Clin Invest, 128, pp.2419~2435 (2018)
34. Lee YA, "Autophagy is a gatekeeper of hepatic differentiation and carcinogenesis by controlling the degradation of Yap", Nat Commun, 9, pp.4962~ (2018)
35. Yang H, "Emerging Players in autophagy deficiency-induced liver injury and tumorigenesis", Gene Expr, 19, pp.229~234 (2019)
36. Martinotti S, "Emerging roles for HMGB1protein in immunity, inflammation, and cancer", Immunotargets Ther, 4, pp.101~109 (2015)
37. Sims GP, "HMGB1 and RAGE in inflammation and cancer", Annu Rev Immunol, 28, pp.367~388 (2010)
38. Arriazu E, "Signalling via the osteopontin and high mobility group box-1 axis drives the fibrogenic response to liver injury", Gut, 66, pp.1123~1137 (2017)
39. Wang H, "HMG-1 as a late mediator of endotoxin lethality in mice", Science, 285, pp.248~251 (1999)
40. Zhao B, "TEAD mediates YAPdependent gene induction and growth control", Genes Dev, 22, pp.1962~1971 (2008)
41. Zhao B, "Both TEAD-binding and WW domains are required for the growth stimulation and oncogenic transformation activity of yes-associated protein", Cancer Res, 69, pp.1089~1098 (2009)
42. Saxton RA, "mTOR signaling in growth, metabolism, and disease", Cell, 169, pp.361~371 (2017)
43. Matter MS, "Targeting the mTOR pathway in hepatocellular carcinoma : current state and future trends", J Hepatol, 60, pp.855~865 (2014)
44. Hu TH, "Expression and prognostic role of tumor suppressor gene PTEN", MMAC1, Cancer, pp.2003, 97[DOI]
45. Ho DWH, "TSC1", 2 mutations define a molecular subset of HCC with aggressive behaviour and treatment implication, 2017, pp.66, 1496~1506
46. Kenerson HL, "Akt and mTORC1 have different roles during liver tumorigenesis in mice", Gastroenterology, 144, pp.1055~1065 (2013)
47. Abraham RT, "The mammalian target of rapamycin signaling pathway : twists and turns in the road to cancer therapy", Clin Cancer Res, 13, pp.3109~3114 (2007)
48. Chiang GG, "Targeting the mTOR signaling network in cancer", Trends Mol Med, 13, pp.433~442 (2007)
49. Liu K, "Mitophagy controls the activities of tumor suppressor p53 to regulate hepatic cancer stem cells", Mol Cell, 68, pp.281~292.e5 (2017)
50. Qian H, "A PINK1-mediated mitophagy pathway decides the fate of tumors-to be benign or malignant?", Autophagy, 14, pp.563~566 (2018)
51. Li X, "Autophagy and autophagy-related proteins in cancer", Mol Cancer, 19, pp.12~ (2020)
52. Barnard RA, "Autophagy inhibition delays early but not late-stage metastatic disease", J Pharmacol Exp Ther, 358, pp.282~293 (2016)
53. Guo JY, "Autophagy-mediated tumor promotion", Cell, 155, pp.1216~1219 (2013)
54. White E, "Deconvoluting the context-dependent role for autophagy in cancer", Nat Rev Cancer, 12, pp.401~410 (2012)
55. Ding WX, "Linking of autophagy to ubiquitin-proteasome system is important for the regulation of endoplasmic reticulum stress and cell viability", Am J Pathol, 171, pp.513~524 (2007)
56. Ding WX, "Differential effects of endoplasmic reticulum stress-induced autophagy on cell survival", J Biol Chem, 282, pp.4702~4710 (2007)
57. Song J, "Hypoxiainduced autophagy contributes to the chemoresistance of hepatocellular carcinoma cells", Autophagy, 5, pp.1131~1144 (2009)
58. Degenhardt K, "Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis", Cancer Cell, 10, pp.51~64 (2006)
59. Perera RM, "Transcriptional control of autophagy-lysosome function drives pancreatic cancer metabolism", Nature, 524, pp.361~365 (2015)
60. Yang S, "Pancreatic cancers require autophagy for tumor growth", Genes Dev, 25, pp.717~729 (2011)
61. Guo JY, "Autophagy suppresses progression of K-rasinduced lung tumors to oncocytomas and maintains lipid homeostasis", Genes Dev, 27, pp.1447~1461 (2013)
62. Strohecker AM, "Autophagy sustains mitochondrial glutamine metabolism and growth of BrafV600E-driven lung tumors", Cancer Discov, 3, pp.1272~1285 (2013)
63. Rosenfeldt MT, "p53 status determines the role of autophagy in pancreatic tumour development", Nature, 504, pp.296~300 (2013)
64. Santanam U, "Atg7 cooperates with Pten loss to drive prostate cancer tumor growth", Genes Dev, 30, pp.399~407 (2016)
65. Poillet-Perez L, "Autophagy maintains tumour growth through circulating arginine", Nature, 563, pp.569~573 (2018)
66. Dillon BJ, "Incidence and distribution of argininosuccinate synthetase deficiency in human cancers : a method for identifying cancers sensitive to arginine deprivation", Cancer, 100, pp.826~833 (2004)
67. Yang A, "Autophagy sustains pancreatic cancer growth through both cell-autonomous and nonautonomous mechanisms", Cancer Discov, 8, pp.276~287 (2018)
68. Sousa CM, "Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion", Nature, 536, pp.479~483 (2016)
69. Endo S, "Autophagy is required for activation of pancreatic stellate cells, associated with pancreatic cancer progression and promotes growth of pancreatic tumors in mice", Gastroenterology, 152, pp.1492~1506.e24 (2017)
70. Yamamoto K, "Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I", Nature, 581, pp.100~105 (2020)
71. Yamamoto K, "Selective autophagy of MHC-I promotes immune evasion of pancreatic cancer", Autophagy, 16, pp.1524~1525 (2020)
72. Pankiv S, "p62", SQSTM1 binds directly to Atg8, J Biol Chem, pp.2007, 282[DOI]
73. Ichimura Y, "Structural basis for sorting mechanism of p62 in selective autophagy", J Biol Chem, 283, pp.22847~22857 (2008)
74. Katsuragi Y, "p62", SQSTM1 functions as a signaling hub and an autophagy adaptor, 2015, pp.282, 4672~4678
75. Manley S, "Role of p62", SQSTM1 in liver physiology and pathogenesis, 2013, pp.238, 525~538
76. Komatsu M, "Physiological significance of selective degradation of p62 by autophagy", FEBS Lett, 584, pp.1374~1378 (2010)
77. Sánchez-Martín P, "p62", SQSTM1-steering the cell through health and disease, 2018, pp.131, jcs222836~
78. Jakobi AJ, "Structural basis of p62", SQSTM1 helical filaments, their presence in p62 bodies and role in cargo recognition in the cell, 2020, pp.11, 440~
79. Wilson MI, "PB1 domainmediated heterodimerization in NADPH oxidase and signaling complexes of atypical protein kinase C with Par6 and p62", Mol Cell, 12, pp.39~50 (2003)
80. Duran A, "p62 is a key regulator of nutrient sensing in the mTORC1 pathway", Mol Cell, 44, pp.134~146 (2011)
81. Katsuragi Y, "Regulation of the Keap1–Nrf2pathway by p62", SQSTM1, 2016, pp.1, 54~61
82. Komatsu M, "The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1", Nat Cell Biol, 12, pp.213~223 (2010)
83. Ichimura Y, "Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy", Mol Cell, 51, pp.618~631 (2013)
84. Jain A, "p62", SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription, 2010, pp.285, 22576~22591
85. Isogai S, "Crystal structure of the ubiquitin-associated(UBA)domain of p62and its interaction with ubiquitin", J Biol Chem, 286, pp.31864~31874 (2011)
86. Taniguchi K, "p62", SQSTM1-Dr. Jekyll and Mr. Hyde that prevents oxidative stress but promotes liver cancer, 2016, pp.590, 2375~2397
87. Umemura A, "p62, upregulated during preneoplasia, induces hepatocellular carcinogenesis by maintaining survival of stressed HCC-initiating cells", Cancer Cell, 29, pp.935~948 (2016)
88. Duran A, "p62", SQSTM1 by binding to vitamin D receptor inhibits hepatic stellate cell activity, fibrosis, and liver cancer, 2016, pp.30, 595~609
89. Saito T, "p62", Sqstm1 promotes malignancy of HCV-positive hepatocellular carcinoma through Nrf2-dependent metabolic reprogramming, 2016, pp.7, 12030~
90. Aishima S, "p62+ hyaline inclusions in intrahepatic cholangiocarcinoma associated with viral hepatitis or alcoholic liver disease", Am J Clin Pathol, 134, pp.457~465 (2010)
91. Xiang X, "Expression of P62 in hepatocellular carcinoma involving hepatitis B virus infection and aflatoxin B1 exposure", Cancer Med, 6, pp.2357~2369 (2017)
92. Menk M, "Chronic alcohol consumption inhibits autophagy and promotes apoptosis in the liver", Int J Med Sci, 15, pp.682~688 (2018)
93. Fukushima H, "Formation of p62-positive inclusion body is associated with macrophage polarization in non-alcoholic fatty liver disease", Hepatol Res, 48, pp.757~767 (2018)
94. González-Rodríguez A, "Impaired autophagic flux is associated with increased endoplasmic reticulum stress during the development of NAFLD", Cell Death Dis, 5, pp.e1179~ (2014)
95. Bartolini D, "Nrf2-p62autophagy pathway and its response to oxidative stress in hepatocellular carcinoma", Transl Res, 193, pp.54~71 (2018)
96. Settembre C, "Signals from the lysosome : a control centre for cellular clearance and energy metabolism", Nat Rev Mol Cell Biol, 14, pp.283~296 (2013)
97. Settembre C, "A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB", EMBO J, 31, pp.1095~1108 (2012)
98. Settembre C, "TFEB links autophagy to lysosomal biogenesis", Science, 332, pp.1429~1433 (2011)
99. Palmieri M, "mTORC1-independent TFEB activation via Akt inhibition promotes cellular clearance in neurodegenerative storage diseases", Nat Commun, 8, pp.14338~ (2017)
100. Li Y, "Protein kinase C controls lysosome biogenesis independently of mTORC1", Nat Cell Biol, 18, pp.1065~1077 (2016)
101. Sha Y, "STUB1 regulates TFEB-induced autophagy-lysosome pathway", EMBO J, 36, pp.2544~2552 (2017)
102. Medina DL, "Lysosomal calcium signalling regulates autophagy through calcineurin and TFEB", Nat Cell Biol, 17, pp.288~299 (2015)
103. Wang Y, "Acetyltransferase GCN5 regulates autophagy and lysosome biogenesis by targeting TFEB", EMBO Rep, 21, pp.e48335~ (2020)
104. Bao J, "Deacetylation of TFEB promotes fibrillar Aβ degradation by upregulating lysosomal biogenesis in microglia", Protein Cell, 7, pp.417~433 (2016)
105. Tanaka M, "Modeling alveolar soft part sarcoma unveils novel mechanisms of metastasis", Cancer Res, 77, pp.897~907 (2017)
106. Ploper D, "MITF drives endolysosomal biogenesis and potentiates Wnt signaling in melanoma cells", Proc Natl Acad Sci U S A, 112, pp.E420~E429 (2015)
107. Mendel L, "Comprehensive study of three novel cases of TFEB-amplified renal cell carcinoma and review of the literature : Evidence for a specific entity with poor outcome", Genes Chromosomes Cancer, 57, pp.99~113 (2018)
108. Argani P, "A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11. 2;q23)", Oncogene, 22, pp.5374~5378 (2003)
109. Clark J, "Fusion of splicing factor genes PSF and NonO(p54nrb)to the TFE3 gene in papillary renal cell carcinoma", Oncogene, 15, pp.2233~2239 (1997)
110. Di Malta C, "Transcriptional activation of RagD GTPase controls mTORC1 and promotes cancer growth", Science, 356, pp.1188~1192 (2017)
111. Sancak Y, "Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids", Cell, 141, pp.290~303 (2010)
112. Schmidt LS, "FLCN : the causative gene for Birt-Hogg-Dubé syndrome", Gene, 640, pp.28~42 (2018)
113. Tsun ZY, "The folliculin tumor suppressor is a GAP for the RagC", D GTPases that signal amino acid levels to mTORC1, 2013, pp.52, 495~505
114. Baba M, "Kidney-targeted Birt-Hogg-Dube gene inactivation in a mouse model : Erk1", 2 and Akt-mTOR activation, cell hyperproliferation, and polycystic kidneys, 2008, pp.100, 140~154
115. Napolitano G, "A substrate-specific mTORC1 pathway underlies Birt-Hogg-Dubé syndrome", Nature (2020)[DOI]
116. Chao X, "Insufficient autophagy : a novel autophagic flux scenario uncovered by impaired liver TFEB-mediated lysosomal biogenesis from chronic alcohol-drinking mice", Autophagy, 14, pp.1646~1648 (2018)
117. Zhang Z, "The unfolded protein response regulates hepatic autophagy by sXBP1-mediated activation of TFEB", Autophagy (2020)[DOI]
118. Michalopoulos GK, "The regenerative altruism of hepatocytes and cholangiocytes", Cell Stem Cell, 23, pp.11~12 (2018)
119. Deng X, "Chronic liver injury induces conversion of biliary epithelial cells into hepatocytes", Cell Stem Cell, 23, pp.114~122.e3 (2018)
120. Schaub JR, "De novo formation of the biliary system by TGFβ-mediated hepatocyte transdifferentiation", Nature, 557, pp.247~251 (2018)
121. Pastore N, "TFEB regulates murine liver cell fate during development and regeneration", Nat Commun, 11, pp.2461~ (2020)
122. Chalhoub N, "PTEN and the PI3-kinase pathway in cancer", Annu Rev Pathol, 4, pp.127~150 (2009)
123. Mora A, "PDK1, the master regulator of AGC kinase signal transduction", Semin Cell Dev Biol, 15, pp.161~170 (2004)
124. Sarbassov DD, "Phosphorylation and regulation of Akt", PKB by the rictor-mTOR complex, 2005, pp.307, 1098~1101
125. Engelman JA, "The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism", Nat Rev Genet, 7, pp.606~619 (2006)
126. Manning BD, "Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase", akt pathway, 2002, pp.10, 151~162
127. Inoki K, "TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling", Nat Cell Biol, 4, pp.648~657 (2002)
128. Inoki K, "TSC2 mediates cellular energy response to control cell growth and survival", Cell, 115, pp.577~590 (2003)
129. Hawley SA, "Complexes between the LKB1 tumor suppressor, STRAD alpha", beta and MO25 alpha, J Biol, pp.2003, 2[DOI]
130. Woods A, "LKB1 is the upstream kinase in the AMP-activated protein kinase cascade", Curr Biol, 13, pp.2004~2008 (2003)
131. Hemminki A, "A serine", threonine kinase gene defective in Peutz-Jeghers syndrome, 1998, pp.391, 184~187
132. Horie Y, "Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas", J Clin Invest, 113, pp.1774~1783 (2004)
133. Ueno T, "Loss of Pten, a tumor suppressor, causes the strong inhibition of autophagy without affecting LC3 lipidation", Autophagy, 4, pp.692~700 (2008)
134. Menon S, "Chronic activation of mTOR complex 1 is sufficient to cause hepatocellular carcinoma in mice", Sci Signal, 5, pp.ra24~ (2012)

관련 논문AI추천